Development of the PHASE-Proxy scale for rating drug-related signs and symptoms in severe cognitive impairment

References

• Arons, A.M., Krabbe, P.F., Schölzel-Dorenbos, C.J., van der Wilt, G.J., & Rikkert, M.G. (2013). Quality of life in dementia: A study on proxy bias. BMC Medical Research Methodology, 13, 110–119. doi:10.1186/1471-2288-13-110
   PubMed Web of Science ®Google Scholar
• Bergland, Å., Kirkevold, M., Sandman, P.-O., Hofoss, D., Vassbø, T., & Edvardsson, D. (2014). Thriving in long-term care facilities: Instrument development, correspondence between proxy and residents' self-ratings and internal consistency in the Norwegian version. Journal of Advanced Nursing, 70, 1672–1681. doi:10.1111/jan.12332
   PubMed Web of Science ®Google Scholar
• Bowyer, P., Lee, J., Kramer, J., Taylor, R.R., & Kielhofner, G. (2012). Determining the clinical utility of the Short Child Occupational Profile (SCOPE). British Journal of Occupational Therapy, 1, 19–26. doi:10.4276/030802212X13261082051373
   Web of Science ®Google Scholar
• Boyer, F., Novella, J.L., Morrone, I., Jolly, D., & Blanchard, F. (2004). Agreement between dementia patient report and proxy reports using the Nottingham Health Profile. International Journal of Geriatric Psychiatry, 19, 1026–1034. doi:10.1002/gps.1191
   PubMed Web of Science ®Google Scholar
• Cancelli, J., Massililiano, B., Gigli, G.L., & Valente, M. (2009). Drugs with anticholinergic properties: Cognitive and neuropsychiatric side-effects in elderly patients. Neurological Sciences, 30, 87–92. doi:10.1007/s10072-009-0033-y
   PubMed Web of Science ®Google Scholar
• Fox, C., Richardson, K., Maidment, I.D., Savva, G.M., Matthews, F.E., Smithard, D., … Brayne, C. (2011). Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study (CFAS). Journal of the American Geriatric Society, 59, 1477–1483. doi:10.1111/j.1532-5415.2011.03491.x
   PubMed Web of Science ®Google Scholar
• Glad, J., Jergeby, U., Gustafsson, C., & Sonnander, K. (2012). Social work practitioners’ experience of the clinical utility of the Home Observation for Measurement of the Environment (HOME) Inventory. Child and Family Social Work, 17, 23–33. doi:10.1111/j.1365-2206.2011.00769.x
   Web of Science ®Google Scholar
• Gräske, J., Fisher, T., Kuhlmey, A., & Wolf-Osterman, K. (2012). Quality of life in dementia care – differences in quality of life measurements performed by residents with dementia and by nursing staff. Aging & Mental Health, 7, 819–827. doi:10.1080/13607863.2012.667782
   Web of Science ®Google Scholar
• Gustafsson, M., Sandman, P.-O., Karlsson, S., Isaksson, U., Schneede, J., Sjölander, M., & Lövheim, H. (2015). Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013. European Journal of Clinical Pharmacology, 71, 507–515. doi:10.1007/s00228-015-1825-z
   PubMed Web of Science ®Google Scholar
• Hedström, M., Lidström, B., & Hulter Åsberg, K. (2009). PHASE-20: ett nytt instrument för skattning av möjliga läkemedelsrelaterade symptom hos äldre personer i äldreboende [PHASE-20: A new instrument for assessment of possible therapeutic drug-related symptoms among elderly in nursing homes]. Vård i Norden, 29, 9–14.
   Google Scholar
• Jensen-Dahm, C., Vogel, A., Waldorff, F.B., & Waldemar, G. (2012). Discrepancy between self- and proxy-rated pain in Alzheimer's disease: Results from the Danish Alzheimer Intervention Study. Journal of the American Geriatrics Society, 60, 1274–1278. doi:10.1111/j.1532-5415.2012.04036.x
   PubMed Web of Science ®Google Scholar
• Lieberman, J.A., (2004). Managing anticholinergic side effects. The Primary Care Companion to the Journal of Clinical Psychiatry, 6(Suppl. 2), 20–23.
   PubMedGoogle Scholar
• Milos, V., Rekman, E., Bondesson, Å., Eriksson, T., Jakobsson, U., Westerlund, T., & Midlöv, P. (2013). Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: A randomized controlled study. Drugs Aging, 30, 235–246. doi:10.1007/s40266-013-0057-0
   PubMed Web of Science ®Google Scholar
• Novella, J.L., Boyer, F., Jochum, C., Jovenin, N., Morrone, I., Jolly, D., … Blanchard, F. (2006). Health status in patients with Alzheimer's disease: An investigation of inter-rater agreement. Quality of Life Research, 15, 811–819. doi:10.1007/sl1136-005-5434-7
   PubMed Web of Science ®Google Scholar
• Nunnally, J.C. (1978). Psychometric theory. New York, NY: McGraw-Hill.
   Google Scholar
• Olsson, J., Bergman, Å., Carlsten, A., Oké, T., Bernsten, C., Schmidt, I., & Fastbom, J. (2010). Quality of drug prescribing in elderly people in nursing homes and special care units for dementia. A cross-sectional computerized pharmacy register analysis. Clinical Drug Investigation, 30, 289–300. doi:10.2165/11534320-000000000-00000
   PubMed Web of Science ®Google Scholar
• Rochon, P.A., & Gurwitz, J.H. (1997). Optimising drug treatment for elderly people: The prescribing cascade. British Medical Journal, 315, 1096–1099.
   PubMed Web of Science ®Google Scholar
• Sheehan, B.D., Lall, R., Stinton, C., Mitchell, K., Gage, H., & Katz, J. (2012). Patient and proxy measurement of quality of life among general hospital in-patients with dementia. Aging & Mental Health, 5, 603–607. doi:10.1080/13607863.2011.653955
   Web of Science ®Google Scholar
• Streiner, D.L., & Norman, G.R. (2008). Health measurement scales: A practical guide to their development and use (4th ed.). Oxford: Oxford University Press.
   Google Scholar
• The Swedish National Board of Health and Welfare. (2010). Indikatorer för god läkemedelsterapi hos äldre [Indicators for evaluating the quality of older people's drug therapy] (publication no. 2010-6-29). Retrieved from http://www.socialstyrelsen.se
   Google Scholar
• The Swedish National Board of Health and Welfare. (2012). SOSFS Statues 2012:9. [in Swedish]. Retrieved from http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18766/2012-6-43.pdf
   Google Scholar